XP-828L in the treatment of mild-to-moderate psoriasis: a randomized, double-blind, placebo-controlled study. - Poulin Y; Bissonnette R; Juneau C; Cantin K; Drouin R; Poubelle PE (Alternative Medicine Review, 2007)